BDR Pharma expands its most trusted Anti-Cancer brand of Enzalutamide Launches BDENZA 160 mg strength critical to the treatment of Prostate Cancer
Mumbai, 28 February, 2022 (GPN): BDR Pharmaceuticals, well known for its most trusted and valuable brand ENZALUTAMIDE with brand name BDENZA launches the medicine in 160mg strength aiding the convenience of Prostate Cancer patients. This…